Dori Pelled
Geschäftsführer bei Imel Biotherapeutics, Inc.
Aktive Positionen von Dori Pelled
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Imel Biotherapeutics, Inc.
 Imel Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Imel Biotherapeutics, Inc. develops treatment for mitochondrial disease. The company was founded on February 21, 2019 and is headquartered in United States. | Geschäftsführer | 01.03.2019 | - |
Karriereverlauf von Dori Pelled
Ehemalige bekannte Positionen von Dori Pelled
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ELOXX PHARMACEUTICALS, INC. | Geschäftsführer | - | 25.06.2018 |
| Corporate Officer/Principal | 25.06.2018 | 01.07.2018 | |
| ENZYMOTEC LTD. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Dori Pelled
| Tel-Aviv University | Graduate Degree |
| Weizmann Institute of Science | Doctorate Degree |
Statistik
International
| Israel | 4 |
| Vereinigte Staaten | 3 |
Operativ
| Chief Operating Officer | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ELOXX PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Enzymotec Ltd.
 Enzymotec Ltd. BiotechnologyHealth Technology Enzymotec Ltd. develops and manufactures bio functional ingredients for health needs. The company was founded on March 8, 1998 and is headquartered in Migdal HaEmeq, Israel. | Health Technology |
Imel Biotherapeutics, Inc.
Imel Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Imel Biotherapeutics, Inc. develops treatment for mitochondrial disease. The company was founded on February 21, 2019 and is headquartered in United States. | Commercial Services |
- Börse
- Insiders
- Dori Pelled
- Erfahrung
